Training future researchers in kidney, urological, and blood diseases.
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)
This program is all about helping new researchers learn how to tackle tricky health questions related to kidneys, urinary issues, and blood disorders by working together, so they can come up with better treatments and care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-10975147 on NIH RePORTER |
What this research studies
This program focuses on training the next generation of researchers in kidney, urological, and hematological fields by promoting interdisciplinary collaboration. It aims to equip investigators with the necessary skills and knowledge to address complex questions that span these overlapping areas of medicine. By leveraging the expertise of four leading medical schools in New York City, the program fosters an environment where innovative research can thrive, ultimately enhancing patient care and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in participating in or benefiting from advancements in kidney, urological, and hematological health.
Not a fit: Patients with conditions unrelated to kidney, urological, or hematological diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and care for patients suffering from kidney, urological, and blood diseases.
How similar studies have performed: Other interdisciplinary training programs have shown success in enhancing research collaboration and improving patient outcomes in related fields.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Kaskel, Frederick Jeffrey — Albert Einstein College of Medicine
- Study coordinator: Kaskel, Frederick Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.